Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Orphenadrine Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Orphenadrine Treatment Report

Brand Names: Norflex
See also: Orphenadrine-aspirin-caffeine

What is Orphenadrine? Orphenadrine is an anti-Parkinson's and skeletal muscle relaxant. It is used in the treatment of muscle spasm and tremors associated with musculoskeletal conditions.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

7 patients in the community are taking or have taken Orphenadrine.

Reason # Patients Percentage of patients
Other 1 14%
Pain 1 14%
Stiffness/Spasticity 1 14%
Insomnia 1 14%

Other treatments patients are taking for Other include Walking Stick/Cane, MRI, and Levothyroxine.

Dosages

Based on the patients currently taking Orphenadrine.

  200 as needed 100 mg daily 300 mg daily
  1 Number of Patients: 1 4 Number of Patients: 4 2 Number of Patients: 2  

Duration

How long current patients have been taking Orphenadrine or how long patients were taking Orphenadrine before stopping.

Currently Taking Orphenadrine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
2

Patient Reported Evaluations

Results from 2 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

There is currently no efficacy data for Orphenadrine.

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 2

Top reported side-effects include:

Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 2)

  • holmesa
    Sex: F
    Mouth/throat: none
    Arms: mild
    Chest: mild
    Legs: mild
  • holmesa
  • by holmesa
    Jun 09, 2009
  • EfficacyMajor
  • Side-effectsNone
  • Stiffness/Spasticity

See all evaluation results for Orphenadrine

Report created on November 07, 2009.